ARTH 0.93 (-7.92%)
US03939W1099BiotechnologyBiotechnology

Arch Therapeutics (ARTH) Stock Highlights

0.93 | -7.92%
2024-05-04 04:19:35
Arch Therapeutics Inc is a development-stage biotechnology company. It focuses on developing products that manage surgery and interventional care faster and safer by using a novel approach to stop bleeding, control leaking, and provide other advantages during surgery and trauma care. The companys primary product candidate, collectively known as the AC5 Devices (AC5), is designed to achieve hemostasis in surgical procedures. The company operates its business operations in the United States.

Statistics

Range Today
1 1.06
Volume Today 10.36K
Range 1 Year
0.39 18
Volume 1 Year 2.17M
Range 3 Year
0.39 28
Volume 3 Year 2.97M
Range 10 Year
0.39 189
Volume 10 Year 6.27M

Highlights

Market Capitalization 4.79M (micro)
Floating Shares 2.81M
Current Price 0.93
Price To Earnings -0.72
Price To Revenue 98.19
Earnings Per Share -1.4
Payout Ratio 0%

Performance

Latest -7.92%
1 Month -49.73%
3 Months -70.19%
6 Months -3.12%
1 Year -66.3%
3 Years -96.42%
5 Years -98.76%
10 Years -98.06%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.